Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market geneonline
Source link : https://news.google.com/rss/articles/CBMizAFBVV95cUxQZGhSLWlZUDVWYXoyVTZqQzBtamVTc0J3dEd0b3hDRmFYLXZVWERKV3N6UmJRa3BYVnY5blBCV0FSN3QtdHpSVkFNbTdoV3hfTk5IalFqUEpHQ294TDZ1SVlfT1lKbnlCcmZBSHZfQUkyN28wa0d5d2FfYmJxMnNIVmtMNDAySmFtLVVPLWNqRFk5Y18zc1ZWeHo2MFYwUVhHNWNxUWdqWWFpYWxqVmNVMmtvaHljRUZKWTBSS2tQUXZkRnB6NVB4MklBRU8?oc=5
Author :
Publish date : 2024-07-03 03:00:00
Copyright for syndicated content belongs to the linked Source.